SummaryBackgroundIntravenous immune globulin (IVIG) for the therapy of dermatomyositis has not been extensively evaluated.Strategies Obtain a PDF of the Research Summary.We carried out a randomized, placebo-controlled trial involving sufferers with lively dermatomyositis. The sufferers have been assigned in a 1:1 ratio to obtain IVIG...